AEMD: Aethlon Medical Inc. Stocks News on April 28, 2025

Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now

AEMD

GlobeNewswire

a month ago

Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

AEMD

PR Newswire

2 months ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

AEMD

GlobeNewswire

2 months ago

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

AEMD

Thomson Reuters StreetEvents

2 months ago

Q3 2025 Aethlon Medical Inc Earnings Call

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

AEMD

PR Newswire

2 months ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

AEMD

Zacks Small Cap Research

2 months ago

AEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol Amendments

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

AEMD

PR Newswire

3 months ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

AEMD

PR Newswire

3 months ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Aethlon Medical treats first subject with Hemopurifier device in Australia

AEMD

Medical Device Network

3 months ago

Aethlon Medical treats first subject with Hemopurifier device in Australia

AEMD

Zacks Small Cap Research

3 months ago

AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

AEMD

PR Newswire

3 months ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

AEMD

PR Newswire

4 months ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now

AEMD

GlobeNewswire

5 months ago

Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now

AEMD

Zacks Small Cap Research

5 months ago

AEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment Measures

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

AEMD

Newsfile

5 months ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

AEMD

GuruFocus.com

5 months ago

Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ...

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

AEMD

PR Newswire

5 months ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

AEMD

Newsfile

6 months ago

Innovative Medical Technology Advances with First Patient Enrollments

Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer

AEMD

Medical Device Network

6 months ago

Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer

AEMD

MT Newswires

6 months ago

Aethlon Medical Enrolls First Patient in Hemopurifier Trial -- Shares Up 14% Pre-Bell

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

AEMD

PR Newswire

6 months ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

AEMD

PR Newswire

6 months ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

AEMD

GlobeNewswire

6 months ago

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

AEMD

Zacks Small Cap Research

6 months ago

OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, Interim CEO & CFO, and Steven LaRosa, MD, Chief Medical Officer, of Aethlon Medical Inc., with Marla Marin, Senior Analyst at Zacks SCR

AEMD

GuruFocus.com

7 months ago

Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ...

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

AEMD

PR Newswire

7 months ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

AEMD

Zacks Small Cap Research

7 months ago

AEMD: Positive Takeaways from Life Science Investor Forum Presentation

Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now

AEMD

GlobeNewswire

7 months ago

Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

AEMD

GlobeNewswire

7 months ago

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

AEMD

Newsfile

7 months ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

AEMD

MT Newswires

7 months ago

Aethlon Medical Receives Ethics Approval for Hemopurifier Cancer Trial in India

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

AEMD

PR Newswire

7 months ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Aethlon Medical to Present at Virtual Investor Conferences in September

AEMD

PR Newswire

7 months ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Innovation Driving Cancer's Solid Tumors Market

AEMD

Newsfile

7 months ago

Innovation Driving Cancer's Solid Tumors Market

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

AEMD

GlobeNewswire

7 months ago

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

AEMD

PR Newswire

7 months ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

AEMD

GlobeNewswire

7 months ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

AEMD

PR Newswire

8 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

AEMD

Zacks Small Cap Research

8 months ago

AEMD: Oncology Trial Advancing; Approval from 2nd Site

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

AEMD

PR Newswire

8 months ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aethlon Medical receives ethics committee approval for trial of cancer treatment

AEMD

Clinical Trials Arena

8 months ago

Aethlon Medical receives ethics committee approval for trial of cancer treatment

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

AEMD

Newsfile

9 months ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

AEMD

MT Newswires

9 months ago

Aethlon Medical Says Hemopurifier Cancer Trial Gets Ethics Committee Approval

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

AEMD

PR Newswire

9 months ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

AEMD

PR Newswire

9 months ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

AEMD

Zacks Small Cap Research

10 months ago

AEMD: Approval from 1st Site, Submitting to Additional Sites for Oncology Trial

AEMD

Insider Monkey

10 months ago

Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2024 Earnings Call Transcript

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

AEMD

PR Newswire

10 months ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

AEMD

Zacks Small Cap Research

10 months ago

AEMD: Ethics Committee Approval for Safety, Feasibility, Dose-Finding Trial Important Step in Advancing the Hemopurifier

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

AEMD

PR Newswire

10 months ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

What's Next in Treatments for Cancer Patients with Solid Tumors?

AEMD

Newsfile

10 months ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

AEMD

PR Newswire

10 months ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

The Hunt for Virus Treatments Continues Post Covid-19

AEMD

Newsfile

a year ago

The Hunt for Virus Treatments Continues Post Covid-19

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

AEMD

Newsfile

a year ago

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

AEMD

PR Newswire

a year ago

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

AEMD

MT Newswires

a year ago

Top Midday Decliners

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

AEMD

PR Newswire

a year ago

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

AEMD

Zacks Small Cap Research

a year ago

AEMD: Data From In Vitro Study Supports Advancing Planned Oncology Clinical Trial

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

AEMD

PR Newswire

a year ago

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

AEMD

PR Newswire

a year ago

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

AEMD

Insider Monkey

a year ago

Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript

AEMD

Zacks Small Cap Research

a year ago

AEMD: Focus on Oncology Studies; In Vitro Binding Study Expected to Advance Clinical Trial Activities

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

AEMD

PR Newswire

a year ago

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

AEMD

PR Newswire

a year ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings

AEMD

GlobeNewswire

a year ago

Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings

Austin Gold Provides Update on Initial Drilling Program at Stockade Mountain Project

AEMD

Newsfile

a year ago

Austin Gold Provides Update on Initial Drilling Program at Stockade Mountain Project

SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market

AEMD

GlobeNewswire

a year ago

SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

AEMD

GlobeNewswire

a year ago

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

Phoenix to Hold Update Webcast/Conference Call Following the Purchase of Proterra's Transit Business

AEMD

ACCESSWIRE

a year ago

Phoenix to Hold Update Webcast/Conference Call Following the Purchase of Proterra's Transit Business

AEMD

GlobeNewswire

a year ago

Fitell Corporation Announces Private Placement of US$3.6 Million of Senior Unsecured Convertible Notes

Leading Independent Proxy Advisory Firm ISS Recommends Shareholders Vote ONLY on the WHITE Proxy Card “FOR” All of Ocean Power Technologies Board Nominees

AEMD

GlobeNewswire

a year ago

Leading Independent Proxy Advisory Firm ISS Recommends Shareholders Vote ONLY on the WHITE Proxy Card “FOR” All of Ocean Power Technologies Board Nominees

Momentus Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

AEMD

Business Wire

a year ago

Momentus Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Guardforce AI Appoints Yuting Zuo as Chief Financial Officer

AEMD

GlobeNewswire

a year ago

Guardforce AI Appoints Yuting Zuo as Chief Financial Officer

AEMD

Business Wire

a year ago

Momentus Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

U.S. Energy Corp. Announces Completion of Asset Divestitures and Provides Liquidity Update

AEMD

GlobeNewswire

a year ago

U.S. Energy Corp. Announces Completion of Asset Divestitures and Provides Liquidity Update

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

AEMD

Benzinga

a year ago

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

AEMD

Zacks Small Cap Research

a year ago

PRTG: Bridging I-O: Working in Harmony with Checkpoints

Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol

AEMD

GlobeNewswire

a year ago

Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol

Portage Biotech Reports Business and Strategic Update

AEMD

GlobeNewswire

a year ago

Portage Biotech Reports Business and Strategic Update

Will Eledon Pharmaceuticals (NASDAQ:ELDN) Spend Its Cash Wisely?

AEMD

Simply Wall St.

a year ago

Will Eledon Pharmaceuticals (NASDAQ:ELDN) Spend Its Cash Wisely?

Clene Announces New Data from HEALEY ALS Platform Trial

AEMD

NewMediaWire

a year ago

Clene Announces New Data from HEALEY ALS Platform Trial

AEMD

Newsfile

a year ago

Austin Gold Corporate Update

Inspira Technologies to Participate in J.P. Morgan Healthcare Conference

AEMD

PR Newswire

a year ago

Inspira Technologies to Participate in J.P. Morgan Healthcare Conference

MDxHealth Announces Completion of Transition to Single Listing on Nasdaq

AEMD

GlobeNewswire

a year ago

MDxHealth Announces Completion of Transition to Single Listing on Nasdaq

Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023

AEMD

InvestorPlace

a year ago

Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023

Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024

AEMD

GlobeNewswire

a year ago

Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024

RYVYL and R3 Partner to Unveil RYVYL Block: Next-Generation Blockchain-as-a-Service Infrastructure

AEMD

GlobeNewswire

a year ago

RYVYL and R3 Partner to Unveil RYVYL Block: Next-Generation Blockchain-as-a-Service Infrastructure

AEMD

GlobeNewswire

a year ago

Chanson International Holding Announces the Plan to Grow Its New Coffee Brand in China

AEMD

PR Newswire

a year ago

HIGHWAY HOLDINGS SIGNS NON-BINDING LETTER OF INTENT TO ACQUIRE MAJORITY OF SYNOVA METALL- UND KUNSTOFFTECHNIK GMBH

Momentus Signs Contract with CalgaryToSpace for 2025 Orbital Delivery Services

AEMD

Business Wire

a year ago

Momentus Signs Contract with CalgaryToSpace for 2025 Orbital Delivery Services

Cenntro Electric Group Announces December 8, 2023 Effective Date for Reverse Stock Split to Regain Nasdaq Compliance

AEMD

Business Wire

a year ago

Cenntro Electric Group Announces December 8, 2023 Effective Date for Reverse Stock Split to Regain Nasdaq Compliance

Hywin and Tencent Cloud Form Strategic Partnership Agreement for Digital Transformation

AEMD

GlobeNewswire

a year ago

Hywin and Tencent Cloud Form Strategic Partnership Agreement for Digital Transformation

Spectral AI to Participate in Benchmark’s 12th Annual Discovery One-on-One Conference

AEMD

GlobeNewswire

a year ago

Spectral AI to Participate in Benchmark’s 12th Annual Discovery One-on-One Conference

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update

AEMD

GlobeNewswire

a year ago

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update

Investors Will Want Harte Hanks' (NASDAQ:HHS) Growth In ROCE To Persist

AEMD

Simply Wall St.

a year ago

Investors Will Want Harte Hanks' (NASDAQ:HHS) Growth In ROCE To Persist

Xcel Brands, Inc. (NASDAQ:XELB) Q3 2023 Earnings Call Transcript

AEMD

Insider Monkey

a year ago

Xcel Brands, Inc. (NASDAQ:XELB) Q3 2023 Earnings Call Transcript

AEMD

Thomson Reuters StreetEvents

a year ago

Q1 2024 Presto Automation Inc Earnings Call

Presto Welcomes Industry Luminary Stephen Herbert as a Strategic Advisor for Presto Touch

AEMD

GlobeNewswire

a year ago

Presto Welcomes Industry Luminary Stephen Herbert as a Strategic Advisor for Presto Touch

Presto Automation Announces Fiscal First Quarter 2024 Financial Results

AEMD

GlobeNewswire

a year ago

Presto Automation Announces Fiscal First Quarter 2024 Financial Results

Insider Sell Alert: CEO O BRIEN DANIEL B Unloads Shares of Flexible Solutions International Inc

AEMD

GuruFocus.com

a year ago

Latest Aethlon Medical Inc. (AEMD) News on April 28, 2025

Share on Social Networks: